Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

Loke Yoon K.; Pradhan Shiva; Yeong Jessica Ka-yan; Kwok Chun Shing

首页> 外文期刊>British Journal of Clinical Pharmacology >Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

【24h】

Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIMS

机译：AIMS

著录项

来源
《British Journal of Clinical Pharmacology》 |2014年第4期|共11页
作者
Loke Yoon K.; Pradhan Shiva; Yeong Jessica Ka-yan; Kwok Chun Shing;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
acute coronary syndrome; apixaban; dabigatran; rivaroxaban;

机译：急性冠状动脉综合征;阿哌沙班;达比加群;利伐沙班;

相似文献

外文文献
中文文献
专利

1. Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison [J] . Loke Yoon K., Pradhan Shiva, Yeong Jessica Ka-yan, British Journal of Clinical Pharmacology . 2014,第4期

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较
2. A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies [J] . Alves C., Mendes D., Batel-Marques F. Drug safety: An international journal of medical toxicology and drug experience . 2019,第10期

机译：Apixaban，Rivaroxaban和Dabigatran的安全性比较：使用现实世界研究的间接治疗比较
3. Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: An indirect comparison analysis [J] . Skj?thF., LarsenT.B., RasmussenL.H., Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2014,第5期

机译：埃达沙班与达比加群，利伐沙班和阿哌沙班在房颤预防中风中的疗效和安全性：间接比较分析
4. Comparative Analysis of Cardiovascular Risk Profile, Cardiac and Cervical Arterial Ultrasound in Patients with Chronic Coronary and Peripheral Arterial Ischemia [C] . M.A. Stoia, A.D. Farcas, F.P. Anton International Conference on Advancements of Medicine and Health Care through Technology . 2017

机译：慢性冠状动脉患者心血管风险，心肌和宫颈动脉超声的比较分析
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Comparative coronary risks of apixaban rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison [O] . Yoon K Loke, Shiva Pradhan, Jessica Ka-yan Yeong, 2014

机译：阿哌沙班利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较
7. Comparative coronary risks of apixaban, rivaroxaban and dabigatran:a meta-analysis and adjusted indirect comparison [O] . Loke, Yoon K, Pradhan, Shiva, Yeong, Jessica Ka-Yan, 2014

机译：阿哌沙班，利伐沙班和达比加群的比较冠心病风险：一项荟萃分析和调整后的间接比较

Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison

摘要

著录项

相似文献

相关主题

期刊订阅